To explore tumorigenesis in CTSV-deficient bladder cancer cells, the CTSV gene expression was reduced in the T24 bladder cancer cell line via the CRISPR/Cas9 mediated gene knockout. This evidence concerns the gene CTSV and urinary bladder carcinoma.